Non-Publication Rates for U.S.-Registered Uveal Melanoma Interventional Studies

United States-registered interventional studies for uveal melanoma were analyzed for publication status. The dataset contains 98 trial records from ClinicalTrials.gov, analyzed in April 2025, with results indicating a 37.76% non-publication rate. It was authored by figshare admin karger and last updated in May 2026.

Use Cases

• Analyzing publication bias based on study characteristics like sponsor type and phase
• Investigating associations between trial termination and result availability
• Comparing publication rates for trials with statistically significant primary endpoints

Strengths

• Includes 98 trial records with 4669 total participants
• Provides a calculated publication probability of 65% with a 95% confidence interval
• Contains specific analysis results, such as a p-value of 0.024 for industry sponsorship association

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Data may reflect geographic bias inherent to the U.S.-focused ClinicalTrials.gov source

Provenance

Source

ClinicalTrials.gov

Collection Method

Database search and manual labeling for publication status

Time Range

Studies completed at least three years prior to an April 2025 search

Freshness

Last updated 2026-05-19 09:55:15; freshness should be verified

Geography

United States